On December 12, 2022 Genmab A/S (Nasdaq: GMAB) reported that it will hold its 2022 R&D Update and ASH (Free ASH Whitepaper) Data Review Meeting today, December 12, 2022 at 8:00 PM Eastern Time (7:00 PM CST / 1:00 AM GMT on December 13) (Press release, Genmab, DEC 12, 2022, View Source [SID1234625110]). The event will take place live at the Four Seasons New Orleans in New Orleans, Louisiana, Plimsole Ballroom B. Those wishing to attend in person may register on site.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The event can also be attended via webcast. To register for the webcast, click here. Webcast viewers may submit questions during the Q&A portion of the live webcast via the webcast player. An archive of the webcast will be available on Genmab’s website. The webcast will be conducted in English.

This meeting is not an official program of the ASH (Free ASH Whitepaper) Annual Meeting.